Article
From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
Genome medicine - 15 Mar 2018
Perera-Bel Júlia, Hutter Barbara, Heining Christoph, Bleckmann Annalen, Fröhlich Martina, Fröhling Stefan, Glimm Hanno, Brors Benedikt, Beißbarth Tim
Abstract excerpt
BACKGROUND: A comprehensive understanding of cancer has been furthered with technological improvements and decreasing costs of next-generation sequencing (NGS). However, the complexity of interpreting genomic data is hindering the implementation of high-throughput technologies in the clinical context: increasing evidence on gene-drug interactions complicates the task of assigning clinical significance to genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
